A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : FasL

Search Conditions:
Search Keyword : FasL
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: FasL
Appearance Frequency: 2485 time(s)
Long forms: 48

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
Fas ligand
(2287 times)
Allergy and Immunology
(601 times)
TNF (111 times)
TNF-alpha (88 times)
sFasL (71 times)
1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Fas-Fas ligand
(78 times)
Allergy and Immunology
(26 times)
sFas (8 times)
sFasL (7 times)
GVHD (3 times)
1996 T cells commit suicide, but B cells are murdered!
Fas and its ligand
(28 times)
Allergy and Immunology
(7 times)
AI (1 time)
AICD (1 time)
bFGF (1 time)
1997 HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.
anti-Fas ligand
(19 times)
Allergy and Immunology
(10 times)
SLE (3 times)
cyt c (2 times)
mAb (2 times)
1999 Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
Fas receptor by its ligand
(8 times)
Allergy and Immunology
(2 times)
AIH (1 time)
BS-IV (1 time)
CFA (1 time)
1997 Fas ligand expression and function in systemic lupus erythematosus.
Fas (Apo-1/CD95) ligand
(6 times)
Hematology
(2 times)
AICD (1 time)
mAb (1 time)
MoAbs (1 time)
1997 Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance.
Fas (CD95/APO-1) ligand
(4 times)
Cardiology
(1 time)
BRK (1 time)
CHX (1 time)
gld (1 time)
2000 Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis.
receptor-Fas ligand
(4 times)
Biochemistry
(1 time)
ECTV (2 times)
OPV (1 time)
TBI (1 time)
2003 Caspase-8 expression and proteolysis in human brain after severe head injury.
factor associated suicide ligand
(3 times)
Biochemistry
(1 time)
Fas (1 time)
HE (1 time)
Lico A (1 time)
2014 Licochalcone A induces apoptosis in KB human oral cancer cells via a caspase-dependent FasL signaling pathway.
10  Fas with its ligand
(3 times)
Pathology
(1 time)
B2M (1 time)
CRP (1 time)
HO-1 (1 time)
1999 [Increased serum soluble Fas ligand in hyperthyroid Graves' disease].
11  anti-Fas antibody or Fas ligand
(2 times)
Allergy and Immunology
(1 time)
CHX (1 time)
ECH (1 time)
FADD (1 time)
2003 Epoxycyclohexenone inhibits Fas-mediated apoptosis by blocking activation of pro-caspase-8 in the death-inducing signaling complex.
12  Fas (CD-95/APO-1) and its ligand
(2 times)
Neoplasms
(2 times)
--- 1999 Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance.
13  Fas ligation with its cognate ligand
(2 times)
Drug Therapy
(1 time)
IL (2 times)
sFas (2 times)
WT (2 times)
2008 Protection against lipopolysaccharide-induced myocardial dysfunction in mice by cardiac-specific expression of soluble Fas.
14  Fas receptor and its cognate ligand
(2 times)
Hematology
(2 times)
--- 1998 Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles.
15  Fas/Apo-1 and its ligand
(2 times)
Medicine
(1 time)
LPC (1 time)
NF-kappaB (1 time)
1997 Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
16  FasR to its natural ligand
(2 times)
Neoplasms
(2 times)
CNS (2 times)
NGF/TNF (2 times)
PCD (2 times)
1999 Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
17  fibroblast-associated cell-surface ligand
(2 times)
Neurology
(1 time)
ALS (1 time)
IL (1 time)
TNF (1 time)
2006 Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
18  anti-Fas Abs or soluble Fas
(1 time)
Allergy and Immunology
(1 time)
--- 1998 Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
19  anti-Fas ligand antibody
(1 time)
Pediatrics
(1 time)
ADR (1 time)
2002 Apoptosis in young rats with adriamycin-induced cardiomyopathy--comparison with pirarubicin, a new anthracycline derivative.
20  apoptosis--Fas, Fas ligand
(1 time)
Ophthalmology
(1 time)
--- 2000 The role of apoptosis in the early corneal wound healing after excimer laser keratectomy in the rat.
21  CTLA4-Fas ligand
(1 time)
Genetics, Medical
(1 time)
AdCTLA4-FasL (1 time)
2004 Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
22  factor receptor superfamily, and its ligand
(1 time)
Biochemistry
(1 time)
--- 1999 Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions.
23  factors--Fas, Fas ligand
(1 time)
Dentistry
(1 time)
ssDNA (1 time)
2001 Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas.
24  family, and its ligand
(1 time)
Allergy and Immunology
(1 time)
TNFR (1 time)
1997 Identification of amino acid residues important for ligand binding to Fas.
25  Fas (Apo-1/CD95) and its specific ligand
(1 time)
Neoplasms
(1 time)
--- 2010 Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
26  Fas (Apo-1/CD95) receptor/ligand
(1 time)
Hematology
(1 time)
mAb (1 time)
1998 On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
27  Fas activation by ligand
(1 time)
Neurology
(1 time)
FADD (1 time)
FLIP (1 time)
RIP (1 time)
1999 Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB.
28  Fas and its physiological ligand
(1 time)
Allergy and Immunology
(1 time)
--- 2012 Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.
29  Fas and its receptor ligand
(1 time)
Pathology
(1 time)
IHC (1 time)
2007 Participation of the Fas and Fas ligand systems in apoptosis during atrophy of the rat submandibular glands.
30  Fas and soluble Fas ligand
(1 time)
Toxicology
(1 time)
EM (1 time)
2008 Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria.
31  Fas antigen ligand
(1 time)
Epidemiology
(1 time)
AREG (1 time)
CRC (1 time)
Flt3L (1 time)
2017 Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer.
32  Fas death ligand
(1 time)
Endocrinology
(1 time)
Dkkl1 (1 time)
2009 Dickkopf-like1 regulates postpubertal spermatocyte apoptosis and testosterone production.
33  Fas interaction with its ligand
(1 time)
Allergy and Immunology
(1 time)
--- 1997 Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
34  Fas ligand molecules
(1 time)
Allergy and Immunology
(1 time)
AICD (1 time)
1997 Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
35  Fas ligand receptors
(1 time)
Biochemistry
(1 time)
--- 2009 Helicobacter pylori increases expression of proapoptotic markers Fas and FasL on CD4 lymphocytes in children.
36  Fas ligand-Fc
(1 time)
Neoplasms
(1 time)
HNSCC (1 time)
2018 Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.
37  Fas natural ligand
(1 time)
Allergy and Immunology
(1 time)
--- 2000 Immature B cells in bone marrow express Fas/FasL.
38  Fas receptor ligand
(1 time)
Biochemistry
(1 time)
ECM (1 time)
PVLA (1 time)
2003 Cell adhesion aside from integrin system can abrogate anoikis in rat liver cells by down-regulation of FasL expression, not by activation of PI-3K/Akt and ERK signaling pathway.
39  Fas receptor with its own ligand
(1 time)
Endocrinology
(1 time)
HT (1 time)
1998 Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
40  Fas with its cognate ligand
(1 time)
Allergy and Immunology
(1 time)
AICD (1 time)
2006 Age related changes in Fas (CD95) and Fas ligand gene expression and cytokine profiles in healthy Indians.
41  Fas with its membrane-bound ligand
(1 time)
Biochemistry
(1 time)
SH3 (1 time)
1995 Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain.
42  Fas-to-Fas-ligand
(1 time)
Endocrinology
(1 time)
--- 2001 Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.
43  Fas/APO-1/CD95 ligand
(1 time)
Reproductive Medicine
(1 time)
Fas (1 time)
RT-PCR (1 time)
2006 Expression and localization of Fas ligand and Fas during atresia in porcine ovarian follicles.
44  fatty acid synthetase ligand
(1 time)
Allergy and Immunology
(1 time)
Apaf-1 (1 time)
Bcl-2 (1 time)
caspase-2 (1 time)
2018 Sodium butyrate enhanced physical barrier function referring to Nrf2, JNK and MLCK signaling pathways in the intestine of young grass carp (Ctenopharyngodon idella).
45  function and concurrent expression of its ligand
(1 time)
Gynecology
(1 time)
RT-PCR (1 time)
2003 Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
46  functional significance of the Fas/Fas-ligand
(1 time)
Cell Biology
(1 time)
--- 2008 The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.
47  functional status of Fas ligand
(1 time)
Neoplasms
(1 time)
--- 2001 Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
48  functional, cell-surface Fas ligand
(1 time)
Allergy and Immunology
(1 time)
--- 2001 Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia.